Join us at the New York Marriott Marquis on February 14-15 for in-person company presentations, educational sessions, and BIO One-on-One Partnering meetings. Educational sessions are also live-streamed for virtual attendees. 

All attendees can view additional educational sessions on February 16 and participate in virtual partnering through February 17.

BIO CEO & Investor Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Conference
Jump to Day
  • Show All
Monday, February 14
12:00 AM - 11:59 PM (EST)

Virtual partnering meetings can be scheduled across all 24 hours by virtual only attendees and…

7:30 AM - 6:00 PM (EST)

Onsite meetings between in-person attendees can be scheduled during these hours.

9:00 AM - 5:00 PM (EST)

Join us for in person Company Presentations.  Watch the schedule for individual…

10:00 AM - 10:45 AM (EST)

 In the midst of the global pandemic, venture funding has continued to…

11:00 AM - 11:45 AM (EST)

Accelerated innovation in oncology has been fueled by a knowledge explosion about cancers at the…

1:00 PM - 1:45 PM (EST)

 

PWC reports that the significant uptick in M&A pharma and life sciences deal…

2:00 PM - 2:45 PM (EST)

Market enthusiasm for ESG (environmental, social, governance) investing is setting new records…

3:00 PM - 3:45 PM (EST)

In this second year of the pandemic, biotech stock indexes have repeatedly swung positive and…

6:00 PM - 7:00 PM (EST)

Welcome Networking Reception at the Marriott Marquis

Tuesday, February 15
12:00 AM - 11:59 PM (EST)

Virtual partnering meetings can be scheduled across all 24 hours by virtual only attendees and…

7:00 AM - 5:30 PM (EST)

In-person attendees can meet during these hours.

9:00 AM - 4:30 PM (EST)

Join us for in person Company Presentations.  Watch the schedule for individual…

10:00 AM - 10:45 AM (EST)

 

Brain diseases are the greatest contributor to the global burden of diseases and…

11:00 AM - 11:45 AM (EST)

 

With the passage of the Build Back Better Act in the House of Representatives, the…

1:00 PM - 1:45 PM (EST)

The CDC cites antibiotic resistance as “one of the biggest public health challenges of our…

2:00 PM - 2:45 PM (EST)

 

In August, the SEC voted to approve corporate board disclosure rules to advance…

3:00 PM - 3:45 PM (EST)

While IPO volume and venture-backed biopharma launches are setting new records, strategic M&…

5:00 PM - 6:00 PM (EST)

Closing Reception at the Marriott Marquis

Wednesday, February 16
12:00 AM - 11:59 PM (EST)

Virtual partnering meetings can be scheduled across all 24 hours by virtual only attendees and…

12:00 PM - 12:45 PM (EST)

In the past decade, the potential to use protein degradation in drug development has moved from…

1:00 PM - 1:45 PM (EST)

In November 2021, US Reps. Diana DeGette (D-CO) and Fred Upton (R-MI) introduced Cures 2.0…

2:00 PM - 2:45 PM (EST)

 

As of June 2021, the FDA has received more than 900 gene therapy applications for…

3:00 PM - 3:45 PM (EST)

At least 50 biopharma companies have gone public via SPAC (special purpose acquisition company)…

Thursday, February 17
12:00 PM - 11:59 PM (EST)

Virtual partnering meetings can be scheduled across all 24 hours by virtual only attendees and…

Available On-Demand
9 Meters Biopharma is a clinical-stage company pioneering novel treatments for people with rare…
AceLink is a clinical-stage biopharmaceutical company focusing on kidney diseases and rare diseases…
Acer is a pharmaceutical company focused on the acquisition, development and commercialization of…
Adjuvance Technologies is a privately-held, clinical-stage biopharmaceutical company empowering…
Aeterna is a specialty biopharmaceutical company developing and commercializing a diversified…
AIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of…
AltruBio is a clinical stage biopharmaceutical company with the strength in developing novel…
AGT is a gene and cell therapy company with a proprietary gene-delivery platform for rapid…
AnHeart Therapeutics (“AnHeart”) is a clinical-stage global biopharmaceutical company developing a…
Aruvant Sciences, a part of the Roivant family of companies, is a clinical-stage biopharmaceutical…
Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the…
aTyr’s mission is to translate novel biological pathways into innovative therapeutics for improved…
Avalo Therapeutics is a leading clinical-stage precision medicine company that discovers, develops,…
Avery Therapeutics is a preclinical-stage company, developing advanced therapies for patients…
Bexion is a clinical-stage biopharmaceutical company whose lead drug candidate, BXQ-350, represents…
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that…
BioMimetix LLC was founded in 2013 to develop the medical and commercial potential of proprietary…
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is a biopharmaceutical company focused on developing,…
Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the…
Castle Creek Biosciences, Inc. is a clinical-stage cell and gene therapy company focused on…
Celeris Therapeutics is the pioneer in AI-driven degrader discovery against currently incurable…
Cend is a clinical-stage biotech company focused on a novel approach to enable more effective…
Chimeric Therapeutics is a clinical stage cell therapy company focused in oncology. Our mission is…
Codagenix is a clinical stage synthetic biology company that uses software to recode the genomes of…
CoImmune is a privately held, clinical stage immuno-oncology company working to redefine cancer…
As a clinical-stage, biopharmaceutical company, we develop innovative cancer medicines based on…
Cyta Therapeutics (Tx) is an early stage company developing its lead product candidate, CYTA-001,…
Daré Bioscience is a clinical-stage biopharmaceutical company committed to advancing innovative…
Double Rainbow is a sustainable health care company. We harness the power of natural to create…
We are a global biotechnology company focused on further improving and leveraging the patented and…
eFFECTOR is a clinical stage biopharmaceutical company focused on pioneering the development of a…
Elpiscience is a global-clinical stage biopharmaceutical company focusing on innovating and…
Clinical stage Oncology biopharmaceutical company leveraging a novel platform technology to…
Engrail Therapeutics is a privately-held biopharma company based in San Diego, CA. At Engrail, we…
Enzychem Lifesciences is a biopharmaceutical company focused on developing oral small molecule…
Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered,…
Broad Spectrum Antivirals – Evrys Bio’s approach to antiviral therapy is different. Uniquely, Evrys…
Exopharm Limited (ASX:EX1) is a clinical-stage company at the forefront of transformative medicines…
Expression Therapeutics is a fully integrated clinical stage gene and cell therapy company…
First Wave BioPharma, Inc. (formerly AzurRx BioPharma) is a clinical stage biopharmaceutical…
The FOXG1 Research Foundation (FRF) is the parent-led global organization driving the research to…
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing…
GeoVax is a clinical-stage biotechnology company developing human vaccines and immunotherapies…
Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of…
Helixmith is a gene therapy company based in Seoul and San Diego, developing new and innovative…
The Company’s lead drug candidate, CRV431, is a potent cyclophilin inhibitor. CRV431 is currently…
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), is a clinical-stage biopharmaceutical company focused…
Immunai uses single-cell genomics and machine learning to discover and develop novel therapeutics…
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company…
IMPACT Therapeutics is a biopharmaceutical company dedicated to the discovery and development of…
INmune Bio is a clinical stage biotechnology company that is developing two platforms that…
Kazia Therapeutics (NASDAQ: KZIA) is a late-clinical-stage oncology company. Our lead asset is…
Kibow Biotech is a Clinical stage biotechnology company pioneering the development and…
Kintara Therapeutics is a clinical stage drug development company with a focus on the development…
Kiora Pharmaceuticals, Inc. (Kiora) is an ophthalmic specialty pharmaceutical company that develops…
Kodikaz is an innovative oncology gene therapeutic company. It's technology platform is a non…
Liminal BioSciences is a global clinical-stage biopharmaceutical company focused on discovering,…
Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage decades of…
MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform…
ASX listed Biotech, focused on nanoparticle delivery platform for enhancing medicines. Lead program…
Mesentech is developing the first pharmaceutical that accelerates bone fracture healing. Mesentech…
Microbion is a clinical stage pharmaceutical company developing a new class of drugs for the…
Moexa Pharmaceuticals Limited (Moexa) is a multi national pre-clinical drug R&D company engaging…
NAKI Therapeutics is an innovative research-focused biopharmaceutical company. Our core technology…
NeoImmuneTech (NIT) is a clinical-stage biopharmaceutical company dedicated to expanding the…
Newron is a biopharmaceutical company focused on the development of novel therapies for patients…
Novome Biotechnologies is a clinical stage biotechnology company developing engineered cellular…
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing…
Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered…
OncoMyx Therapeutics is advancing oncolytic immunotherapies with the goal of achieving the greatest…
OncoOne is a biotech start-up dedicated to developing innovative therapeutics to treat patients…
Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people…
ORYZON is a public clinical stage biopharmaceutical company and the European leader in the…
Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation…
Brett Dines, CEO of OYE Therapeutics, knew the stats: "delayed emergence" from the coma-like state…
Paradigm Biopharmaceuticals LTD (ASX: PAR) is a late-stage drug development company with the…
A privately held, clinical-stage pharmaceutical company currently in Phase 2 development of lead…
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the development,…
Privo Technologies, Inc. (Privo) is a clinical-stage biopharmaceutical company committed to…
ProDa BioTech LLC is founded in Marietta, Georgia in 2012. The mission of ProDa is to develop its…
ProMIS develops antibody based therapies for mis-folded protein driven diseases, including…
Protalix is a biopharmaceutical company focused on the development, production and…
Qualigen is a biotechnology company focused on developing novel therapeutic products for the…
Company will become public end of 2021. Start up company focused on developing…
RareStone is a therapeutics platform company focused on the Greater China market that was co…
RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on…
Rejuvenation is a venture-backed pre-clinical stage biotechnology company out of Stanford…
Renovacor is a biotechnology company focused on delivering innovative precision therapies to…
Revelation Biosciences is a clinical stage life sciences company focused on the development of…
Ripple Therapeutics is a clinical stage therapeutics company focused on improving ophthalmic…
RubrYc Therapeutics, Inc., is a biotechnology company applying proprietary machine-learning…
Safi Biosolutions is a pre-clinical stage blood cell therapy company applying proprietary…
Saghmos Therapeutics is a privately held biopharmaceutical company whose mission is to develop…
Satellos is a biotechnology company dedicated to developing lifechanging medicines that have the…
Henlius established in 2010 is a global biopharmaceutical company with the vision to offer high…
SIWA’s 318H mAb selectively targets a biomarker on cells with a combination of an abnormally high…
Soleno Therapeutics, Inc is focused on the development and commercialization of novel therapeutics…
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing…
The mission of St. Jude is to advance cures, and means of prevention, for pediatric catastrophic…
Step Pharma is developing novel innovative therapies to treat cancer and autoimmune diseases…
Synlogic™ is pioneering the development of a novel class of living Synthetic Biotic™ medicines…
T-Cure Bioscience, Inc. is an innovative immuno-oncology company committed to delivering effective…
Tallac Therapeutics is a privately funded biotech company founded in 2018 by Hong Wan, Jaume Pons,…
Telum Therapeutics SL is a global drug discovery biotechnology company specializing in the use of…
TNA Therapeutics was founded in 2021, however, two of the co-founders have been working on this…
Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring…
Tranquis, a breakthrough clinical-stage biopharmaceutical company, is developing a portfolio of…
As the RNA Oncology Company, TransCode is committed to defeating cancer through the intelligent…
Treovir was founded in 2019 to develop and commercialize G207 for recurrent glioblastoma in…
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of…
Tubulis generates uniquely matched protein-drug conjugates through the combination of novel…
Vascular Biogenics Ltd., operating as VBL Therapeutics (VBL), is a clinical stage biopharmaceutical…
ViCardia is developing a breakthrough therapy, GP-531, a potent, long-lasting, mitotropic agent,…
Vivacitas Oncology is a private clinical stage biopharmaceutical company focused on tough-to-treat…